Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-N-biotinyl-(13-N-succinimidyl-(S-farnesyl-L-cysteinyl)-L-valinyl-L-isoleucinyl-L-alanine)-4,7,10-trioxatridecanediamine-CVIA + H2O
?
1-N-biotinyl-(13-N-succinimidyl-(S-farnesyl-L-cysteinyl)-L-valinyl-L-isoleucinyl-[14C]-L-alanine)-4,7,10-trioxatridecanediamine + H2O
?
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(3-methylbenzophenone geranyl ether)(epsilon-dinitrophenyl-L-lysine)-L-Ile-Met + H2O
?
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(3-methylbenzophenone prenyl ether)(epsilon-dinitrophenyl-L-lysine)-L-Ile-Met + H2O
?
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)(dinitrophenyldiaminopropionic acid)IM + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + (dinitrophenyldiaminopropionic acid)IM
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)(epsilon-dinitrophenyl-L-lysine)-L-Ile-Met + H2O
?
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)(lysine epsilon-dinitrophenyl)IM + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + (lysine epsilon-dinitrophenyl)IM
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)(lysine epsilon-dinitrophenyl)L-Ile-Met + H2O
?
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)VI + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + VI
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)VI(dinitrophenyldiaminopropionic acid) + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + VI(dinitrophenyldiaminopropionic acid)
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)VI(lysine epsilon-dinitrophenyl) + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + VI(lysine epsilon-dinitrophenyl)
Substrates: -
Products: -
?
2-aminobenzoyl-KSKTKC(farnesyl)VIM + H2O
2-aminobenzoyl-KSKTKC(farnesyl) + VIM
Substrates: -
Products: -
?
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)(dinitrophenyldiaminopropionic acid)IM + H2O
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl) + (dinitrophenyldiaminopropionic acid)IM
Substrates: -
Products: -
?
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)(lysine epsilon-dinitrophenyl)IM + H2O
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl) + (lysine epsilon-dinitrophenyl)IM
Substrates: -
Products: -
?
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)VI(dinitrophenyldiaminopropionic acid) + H2O
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl) + VI(dinitrophenyldiaminopropionic acid)
Substrates: -
Products: -
?
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)VI(lysine epsilon-dinitrophenyl) + H2O
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl) + VI(lysine epsilon-dinitrophenyl)
Substrates: -
Products: -
?
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)VIM + H2O
7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl) + VIM
Substrates: -
Products: -
?
acetyl-C(farnesyl)VIA + H2O
acetyl-C(farnesyl) + VIA
-
Substrates: -
Products: -
?
acetyl-C(farnesyl)VIS + H2O
acetyl-C(farnesyl) + VIS
-
Substrates: -
Products: -
?
acetyl-L-Cys(farnesyl)FML + H2O
acetyl-L-Cys(farnesyl) + FML
Substrates: -
Products: -
?
acetyl-L-Cys(farnesyl)L-Arg-Leu + H2O
acetyl-L-Cys(farnesyl) + L-Arg-Leu
Substrates: 6% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Ile-Gln + H2O
acetyl-L-Cys(farnesyl) + L-Ile-Gln
Substrates: 5% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Ile-Met + H2O
acetyl-L-Cys(farnesyl) + L-Ile-Met
Substrates: 47% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Ile-Val + H2O
acetyl-L-Cys(farnesyl) + L-Ile-Val
Substrates: 45% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Leu-Ile + H2O
acetyl-L-Cys(farnesyl) + L-Leu-Ile
Substrates: 50% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Leu-Leu + H2O
acetyl-L-Cys(farnesyl) + L-Leu-Leu
Substrates: 83% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Leu-Met + H2O
acetyl-L-Cys(farnesyl) + L-Leu-Met
Substrates: 120% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Phe-Leu + H2O
acetyl-L-Cys(farnesyl) + L-Phe-Leu
Substrates: 72% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Phe-Met + H2O
acetyl-L-Cys(farnesyl) + L-Phe-Met
Substrates: 51% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Ser-Thr + H2O
acetyl-L-Cys(farnesyl) + L-Ser-Thr
Substrates: 4% activity compared to acetyl-L-Cys(farnesyl)L-Val-Ile
Products: -
?
acetyl-L-Cys(farnesyl)L-Val-Ile + H2O
acetyl-L-Cys(farnesyl) + L-Val-Ile
Substrates: 100% activity
Products: -
?
acetyl-L-Cys(farnesyl)LIL + H2O
acetyl-L-Cys(farnesyl) + LIL
Substrates: -
Products: -
?
acetyl-L-Cys(farnesyl)LLL + H2O
acetyl-L-Cys(farnesyl) + LLL
Substrates: -
Products: -
?
acetyl-L-Cys(farnesyl)LML + H2O
acetyl-L-Cys(farnesyl) + LML
Substrates: -
Products: -
?
acetyl-L-Cys(farnesyl)RLS + H2O
acetyl-L-Cys(farnesyl) + RLS
Substrates: very weak activity
Products: -
?
acetyl-L-Cys(farnesyl)VIS + H2O
acetyl-L-Cys(farnesyl) + VIL
Substrates: -
Products: -
?
acetyl-[3H]farnesyl-CVIS + H2O
acetyl-[3H]farnesyl-C + VIS
Substrates: -
Products: -
?
Dabcyl-ARSGAKASGC(farnesyl)LVS-Edans + H2O
?
Substrates: -
Products: -
?
dansyl-G(farnesyl)CIIL+ H2O
?
Substrates: 6% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-G(farnesyl)CIIS + H2O
?
Substrates: 13% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-G(geranylgeranyl)CIIL+ H2O
?
Substrates: less than 1% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-G(geranylgeranyl)CIIS + H2O
?
Substrates: less than 1% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-GLP(farnesyl)CVVM + H2O
?
Substrates: 13% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-GLP(geranylgeranyl)CVVM + H2O
?
Substrates: 13% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-KTK(farnesyl)CVIM + H2O
?
Substrates: 25% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-KTK(geranylgeranyl)CVIM + H2O
?
Substrates: 2% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-SAK(farnesyl)CVLS + H2O
?
Substrates: 12% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-SAK(geranylgeranyl)CVLS + H2O
?
Substrates: less than 1% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-WDPA(farnesyl)CVIA + H2O
?
Substrates: 100% activity
Products: -
?
dansyl-WDPA(geranylgeranyl)CVIA + H2O
?
Substrates: 12% activity compared to dansyl-WDPA(farnesyl)CVIA
Products: -
?
dansyl-WDPAC(farnesyl)VIA + H2O
?
farnesyl-CVIM + H2O
?
Substrates: -
Products: -
?
farnesyl-GSPCVLM + H2O
?
Substrates: -
Products: -
?
farnesylated a-factor + H2O
?
Substrates: -
Products: -
?
farnesylated Ggamma1 + H2O
?
Substrates: -
Products: -
?
farnesylated Ha-Ras + H2O
?
Substrates: -
Products: -
?
farnesylated Ki-Ras + H2O
?
Substrates: -
Products: -
?
farnesylated N-Ras + H2O
?
Substrates: -
Products: -
?
farnesylated Ras protein + H2O
?
Substrates: -
Products: -
?
farnesylated Ras2 protein + H2O
?
Substrates: -
Products: -
?
geranylgeranylated Ki-Ras + H2O
?
Substrates: -
Products: -
?
geranylgeranylated Rap1b + H2O
?
Substrates: -
Products: -
?
GFP-H-Ras-C(farnesyl)VLS + H2O
?
GFP-K-Ras4a-C(farnesyl)IIM + H2O
?
GFP-K-Ras4b-C(farnesyl)VIM + H2O
?
GFP-N-Ras-C(farnesyl)VVM + H2O
?
GFP-Ras2p-C(farnesyl)IIS + H2O
?
K-Ras + H2O
?
Substrates: -
Products: -
?
K-Ras(farnesyl) + H2O
?
Substrates: -
Products: -
?
KGVFWDPAC(farnesyl)VIA + H2O
?
KSKTKC(farnesyl)VIM + H2O
KSKTKC(farnesyl) + VIM
Substrates: -
Products: -
?
KWDPAC(farnesyl)VIA + H2O
?
mature a-factor peptide-C(farnesyl)VIA + H2O
?
ortho-aminobenzoic acid-KSKTKC(farnesyl)(N6-(2,4-dinitrophenyl)-L-lysine)L-Ile-Met + H2O
?
phosphodiesterase 6 + H2O
?
Substrates: -
Products: -
?
rhodopsin kinase 1+ H2O
?
Substrates: -
Products: -
?
transducin + H2O
?
Substrates: -
Products: -
?
YBL018C CKCI + H2O
?
Substrates: -
Products: -
?
YBL049W CKCT + H2O
?
Substrates: -
Products: -
?
YBL061C CVIM + H2O
?
Substrates: -
Products: -
?
YCR004C CTVM + H2O
?
Substrates: -
Products: -
?
YCR027C CSIM + H2O
?
Substrates: -
Products: -
?
YDL009C CAVS + H2O
?
Substrates: -
Products: -
?
YDR461W CVIA + H2O
?
Substrates: -
Products: -
?
YFL066C CCVC + H2O
?
Substrates: -
Products: -
?
YGL069C CVCC + H2O
?
Substrates: -
Products: -
?
YGL082W CVIM + H2O
?
Substrates: -
Products: -
?
YGR152C CTIL + H2O
?
Substrates: -
Products: -
?
YIIKGVFWDPAC(farnesyl)VIA + H2O
?
YIL118W CTIM + H2O
?
Substrates: -
Products: -
?
YIR007W CVIS + H2O
?
Substrates: -
Products: -
?
YIR032C CIII + H2O
?
Substrates: -
Products: -
?
YJL059W CRME + H2O
?
Substrates: -
Products: -
?
YJL118W CCCS + H2O
?
Substrates: -
Products: -
?
YJL204C CCIM + H2O
?
Substrates: -
Products: -
?
YJR086W CTLM + H2O
?
Substrates: -
Products: -
?
YJR128W CMMI + H2O
?
Substrates: -
Products: -
?
YKL196C CIIM + H2O
?
Substrates: -
Products: -
?
YKR055W CIIM + H2O
?
Substrates: -
Products: -
?
YLL044W CSLY + H2O
?
Substrates: -
Products: -
?
YLR090W CCIQ + H2O
?
Substrates: -
Products: -
?
YLR229C CAIL + H2O
?
Substrates: -
Products: -
?
YLR322W CRIF + H2O
?
Substrates: -
Products: -
?
YLR444C CRCG + H2O
?
Substrates: -
Products: -
?
YML006C CAIM + H2O
?
Substrates: -
Products: -
?
YML116W CTVA + H2O
?
Substrates: -
Products: -
?
YNL090W CIIL + H2O
?
Substrates: -
Products: -
?
YNL098C CIIS + H2O
?
Substrates: -
Products: -
?
YNL145W CVIA + H2O
?
Substrates: -
Products: -
?
YNL180C CVIL + H2O
?
Substrates: -
Products: -
?
YNL234W CSIM+ H2O
?
Substrates: -
Products: -
?
YOL014W CIIL + H2O
?
Substrates: -
Products: -
?
YOR101W CIIC + H2O
?
Substrates: -
Products: -
?
YPL191C CVVM + H2O
?
Substrates: -
Products: -
?
YPR092W CKIS + H2O
?
Substrates: -
Products: -
?
YPR099C CVST + H2O
?
Substrates: -
Products: -
?
YPR165W CVLL+ H2O
?
Substrates: -
Products: -
?
additional information
?
-
1-N-biotinyl-(13-N-succinimidyl-(S-farnesyl-L-cysteinyl)-L-valinyl-L-isoleucinyl-L-alanine)-4,7,10-trioxatridecanediamine-CVIA + H2O

?
Substrates: -
Products: -
?
1-N-biotinyl-(13-N-succinimidyl-(S-farnesyl-L-cysteinyl)-L-valinyl-L-isoleucinyl-L-alanine)-4,7,10-trioxatridecanediamine-CVIA + H2O
?
-
Substrates: -
Products: -
?
dansyl-WDPAC(farnesyl)VIA + H2O

?
Substrates: -
Products: -
?
dansyl-WDPAC(farnesyl)VIA + H2O
?
-
Substrates: -
Products: -
?
GFP-H-Ras-C(farnesyl)VLS + H2O

?
Substrates: -
Products: -
?
GFP-H-Ras-C(farnesyl)VLS + H2O
?
-
Substrates: -
Products: -
?
GFP-K-Ras4a-C(farnesyl)IIM + H2O

?
Substrates: -
Products: -
?
GFP-K-Ras4a-C(farnesyl)IIM + H2O
?
-
Substrates: -
Products: -
?
GFP-K-Ras4b-C(farnesyl)VIM + H2O

?
Substrates: -
Products: -
?
GFP-K-Ras4b-C(farnesyl)VIM + H2O
?
-
Substrates: -
Products: -
?
GFP-N-Ras-C(farnesyl)VVM + H2O

?
Substrates: -
Products: -
?
GFP-N-Ras-C(farnesyl)VVM + H2O
?
-
Substrates: -
Products: -
?
GFP-Ras2p-C(farnesyl)IIS + H2O

?
Substrates: -
Products: -
?
GFP-Ras2p-C(farnesyl)IIS + H2O
?
-
Substrates: -
Products: -
?
KGVFWDPAC(farnesyl)VIA + H2O

?
Substrates: -
Products: -
?
KGVFWDPAC(farnesyl)VIA + H2O
?
-
Substrates: -
Products: -
?
KWDPAC(farnesyl)VIA + H2O

?
Substrates: -
Products: -
?
KWDPAC(farnesyl)VIA + H2O
?
-
Substrates: -
Products: -
?
mature a-factor peptide-C(farnesyl)VIA + H2O

?
Substrates: -
Products: -
?
mature a-factor peptide-C(farnesyl)VIA + H2O
?
-
Substrates: -
Products: -
?
ortho-aminobenzoic acid-KSKTKC(farnesyl)(N6-(2,4-dinitrophenyl)-L-lysine)L-Ile-Met + H2O

?
Substrates: -
Products: -
?
ortho-aminobenzoic acid-KSKTKC(farnesyl)(N6-(2,4-dinitrophenyl)-L-lysine)L-Ile-Met + H2O
?
-
Substrates: -
Products: -
?
YIIKGVFWDPAC(farnesyl)VIA + H2O

?
Substrates: -
Products: -
?
YIIKGVFWDPAC(farnesyl)VIA + H2O
?
-
Substrates: -
Products: -
?
additional information

?
-
Substrates: the enzyme has the ability to promote production of the farnesylated yeast pheromone a-factor in vivo
Products: -
-
additional information
?
-
Substrates: no activity with unprenylated substrates (CVIM and GSPCVLM)
Products: -
-
additional information
?
-
Substrates: no activity with KSKTKC(farnesyl), 7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)VIM, 7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl), MCA-KSKTKC(farnesyl)V(lysine epsilon-dinitrophenyl)M, MCA-KSKTKC(farnesyl)V(dinitrophenyldiaminopropionic acid)M, 7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl)V, 7-methoxycoumarin-4-acetyl-KSKTKC(farnesyl), 2-aminobenzoyl-KSKTKC(farnesyl)V(lysine epsilon-dinitrophenyl)M , 2-aminobenzoyl-KSKTKC(farnesyl)V(dinitrophenyldiaminopropionic acid)M , and 2-aminobenzoyl-KSKTKC(farnesyl)VI(dinitrophenyldiaminopropionic acid)
Products: -
-
additional information
?
-
Substrates: in terms of isoprenylation, the enzyme cleaves substrates modified with either C15 and C20, but not unprenylated substrates
Products: -
-
additional information
?
-
-
Substrates: in terms of isoprenylation, the enzyme cleaves substrates modified with either C15 and C20, but not unprenylated substrates
Products: -
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2S,5R,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-[(benzylsulfanyl)methyl]-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
(2S,5S,8R,15E,19E)-11-acetamido-5-benzyl-2-[2-(benzyloxy)-2-oxoethyl]-8-[(benzylsulfanyl)methyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
(2S,5S,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-(butan-2-yl)-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
(2S,5S,8S,15E,19E)-11-acetamido-5-benzyl-8-[1-(benzyloxy)ethyl]-2-[2-(benzyloxy)-2-oxoethyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
(6R,7S,11S,14S,17S)-14-(butan-2-yl)-7-hydroxy-2,2-dimethyl-17-[2-(methylsulfanyl)ethyl]-4,9,12,15-tetraoxo-11-(propan-2-yl)-6-([[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl]methyl)-3-oxa-5,10,13,16-tetraazaoctadecan-18-oic acid
-
-
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide
1,10-phenanthroline
about 20% residual activity at 5 mM
1,2,3,4,5,6,7,8,13,13,14,14-dodecachloro-11-sulfo-1,4,4a,4b,5,8,8a,12b-octahydro-1,4:5,8-dimethanotriphenylene-10-carboxylic acid
1,4,5,6,7,7-hexachloro-3-[(9H-fluoren-2-yl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
1,7-phenanthroline
about 20% residual activity at 5 mM
2-[(4-bromo-2,6-difluorophenyl)(phenylamino)methyl]naphthalen-1-ol
2-[(4-tert-butylanilino)(phenyl)methyl]naphthalen-1-ol
2-[phenyl(phenylamino)methyl]naphthalen-1-ol
20,24-bishomoscalarane ketal
-
3-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
4-bromo-2-[phenyl(phenylamino)methyl]naphthalen-1-ol
4-hydroxy-mercuriphenylsulfonic acid
4-hydroxymercuribenzoic acid
4-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
4-[[(4-bromo-2,6-difluorophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
4-[[(4-bromophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
4-[[(4-bromophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
4-[[(4-cyanophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
4-[[(4-fluorophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
4-[[(8-hydroxyquinolin-7-yl)(4-methylphenyl)methyl]amino]benzoic acid
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoic acid
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzonitrile
4-[[cyclohexyl(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1H-1,2,3-triazole-4-carboxamide
7-[(4-nitrophenyl)(phenylamino)methyl]quinolin-8-ol
7-[phenyl(phenylamino)methyl]quinolin-8-ol
7-[[(4-methylphenyl)amino](phenyl)methyl]quinolin-8-ol
acetyl-L-Cys(farnesyl)-L-Ala-Ala
24% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ala-Gly
18% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ala-Leu
48% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Arg-Arg
42% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Arg-Asp
17% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Arg-Ile
72% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Arg-Leu
72% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Arg-Val
60% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Asn-Asp
17% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Asn-Ile
40% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Asn-Leu
47% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Cys-Gly
48% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Cys-Leu
78% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Cys-Met
56% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Cys-Ser
35% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Cys-Val
52% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Gln-Asn
18% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Gln-Asp
10% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Gln-Ile
51% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Gln-Leu
59% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-His-Asp
8% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-His-Ser
25% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ile-Asp
5% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ile-Gln
33% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ile-Ile
83% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ile-Met
82% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ile-Val
86% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Leu-Asp
9% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Leu-Ile
83% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Leu-Leu
84% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Leu-Met
84% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Leu-Ser
60% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Ala
30% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Asp
13% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Ile
45% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Met
25% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Phe
34% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Ser
17% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Lys-Val
30% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Phe-Ala
80% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Phe-Leu
86% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Phe-Met
82% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Phe-Thr
71% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Phe-Val
84% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Ala
23% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Asn
12% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Asp
9% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Gly
21% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Ile
53% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Leu
53% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Phe
57% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Pro
20% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Ser
13% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Thr
22% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Ser-Val
32% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Thr-Arg
29% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Thr-Gly
26% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Thr-Ile
57% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Thr-Val
37% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-trp-Gln
55% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Trp-Pro
57% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Tyr-Leu
69% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Tyr-Pro
48% inhibition at 0.04 mM
-
acetyl-L-Cys(farnesyl)-L-Tyr-Thr
38% inhibition at 0.04 mM
-
Co2+
52% residual activity at 0.087 mM
Cu2+
3% residual activity at 0.087 mM
dansyl-G(farnesyl)CIIL
53% inhibition at 0.05 mM
-
dansyl-G(geranylgeranyl)CIIL
67% inhibition at 0.05 mM
-
dansyl-G(geranylgeranyl)CIIS
-
-
dansyl-GLP(farnesyl)CVVM
-
dansyl-GLP(geranylgeranyl)CVVM
-
-
dansyl-KTK(farnesyl)CVIM
-
dansyl-KTK(geranylgeranyl)CVIM
-
-
dansyl-SAK(farnesyl)CVLS
-
dansyl-SAK(geranylgeranyl)CVLS
41% inhibition at 0.05 mM
-
dansyl-WDPA(farnesyl)CVIA
-
dansyl-WDPA(geranylgeranyl)CVIA
-
EDTA
about 80% residual activity at 5 mM
ethyl 4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoate
Fe2+
72% residual activity at 0.087 mM
methanesulfonic acid
1% residual activity at 0.022 mM
methyl methanethiosulfonate
60% residual activity at 0.05 mM
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide
N-acetyl-S-farnesyl-L-cysteine
-
N-acetyl-S-farnesyl-L-cysteine chloromethyl ketone
-
-
N-acetyl-S-farnesyl-L-cysteine diazomethyl ketone
-
-
N-acetyl-S-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cysteinyl-L-valyl-L-isoleucyl-L-alanine
N-tert-Boc-S-farnesyl-L-cysteine chloromethyl ketone
-
N-[(2R)-2-[(tert-butoxycarbonyl)amino]-3-[[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]sulfanyl]propyl]-L-valyl-L-isoleucyl-L-methionine
-
-
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide
Nalpha-tosyl-L-lysine chloromethyl ketone
Nalpha-tosyl-L-phenylalanine chloromethyl ketone
Ni2+
52% residual activity at 0.087 mM
non-peptidyl non-prenylic inhibitor A
-
-
non-peptidyl non-prenylic inhibitor B
-
-
non-peptidyl non-prenylic inhibitor C
-
-
o-phenanthroline
46% residual activity at 5 mM
p-phenanthroline
70% residual activity at 5 mM
poly(methylhydrosiloxane)
1% residual activity at 0.022 mM
-
polyhexamethylenbiguanide
1% residual activity at 0.022 mM
-
tosyl-L-lysine chloromethyl ketone
68% residual activity at 0.3 mM, 54% residual activity at 1 mM
tosyl-L-phenylalanine chloromethyl ketone
6% residual activity at 0.3 mM
tosylphenylalanylchloromethane
-
Zn2+
1% residual activity at 0.087 mM
(2S,5R,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-[(benzylsulfanyl)methyl]-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid

-
(2S,5R,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-[(benzylsulfanyl)methyl]-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
-
-
(2S,5S,8R,15E,19E)-11-acetamido-5-benzyl-2-[2-(benzyloxy)-2-oxoethyl]-8-[(benzylsulfanyl)methyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid

-
(2S,5S,8R,15E,19E)-11-acetamido-5-benzyl-2-[2-(benzyloxy)-2-oxoethyl]-8-[(benzylsulfanyl)methyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
-
-
(2S,5S,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-(butan-2-yl)-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid

-
(2S,5S,8S,15E,19E)-11-acetamido-2-[2-(benzyloxy)-2-oxoethyl]-5-(butan-2-yl)-8,16,20,24-tetramethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
-
-
(2S,5S,8S,15E,19E)-11-acetamido-5-benzyl-8-[1-(benzyloxy)ethyl]-2-[2-(benzyloxy)-2-oxoethyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid

-
(2S,5S,8S,15E,19E)-11-acetamido-5-benzyl-8-[1-(benzyloxy)ethyl]-2-[2-(benzyloxy)-2-oxoethyl]-16,20,24-trimethyl-4,7,10-trioxo-13-thia-3,6,9-triazapentacosa-15,19,23-trien-1-oic acid
-
-
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide

-
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide
-
non-peptidyl non-prenylic inhibitor A
1,2,3,4,5,6,7,8,13,13,14,14-dodecachloro-11-sulfo-1,4,4a,4b,5,8,8a,12b-octahydro-1,4:5,8-dimethanotriphenylene-10-carboxylic acid

-
1,2,3,4,5,6,7,8,13,13,14,14-dodecachloro-11-sulfo-1,4,4a,4b,5,8,8a,12b-octahydro-1,4:5,8-dimethanotriphenylene-10-carboxylic acid
-
-
1,4,5,6,7,7-hexachloro-3-[(9H-fluoren-2-yl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid

-
1,4,5,6,7,7-hexachloro-3-[(9H-fluoren-2-yl)carbamoyl]bicyclo[2.2.1]hept-5-ene-2-carboxylic acid
-
-
2-[(4-bromo-2,6-difluorophenyl)(phenylamino)methyl]naphthalen-1-ol

-
2-[(4-bromo-2,6-difluorophenyl)(phenylamino)methyl]naphthalen-1-ol
-
-
2-[(4-tert-butylanilino)(phenyl)methyl]naphthalen-1-ol

-
2-[(4-tert-butylanilino)(phenyl)methyl]naphthalen-1-ol
-
-
2-[phenyl(phenylamino)methyl]naphthalen-1-ol

-
2-[phenyl(phenylamino)methyl]naphthalen-1-ol
-
-
20,24-bishomoscalarane ketal

-
-
20,24-bishomoscalarane ketal
-
-
-
3-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid

-
3-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
-
-
4-bromo-2-[phenyl(phenylamino)methyl]naphthalen-1-ol

-
4-bromo-2-[phenyl(phenylamino)methyl]naphthalen-1-ol
-
-
4-hydroxy-mercuriphenylsulfonic acid

-
4-hydroxy-mercuriphenylsulfonic acid
-
-
4-hydroxymercuribenzoic acid

-
4-hydroxymercuribenzoic acid
-
-
4-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid

-
4-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
-
-
4-[[(4-bromo-2,6-difluorophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid

-
4-[[(4-bromo-2,6-difluorophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
-
-
4-[[(4-bromophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid

-
4-[[(4-bromophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
-
-
4-[[(4-bromophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid

-
4-[[(4-bromophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
-
-
4-[[(4-cyanophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid

-
4-[[(4-cyanophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
-
-
4-[[(4-fluorophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid

-
4-[[(4-fluorophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
-
-
4-[[(8-hydroxyquinolin-7-yl)(4-methylphenyl)methyl]amino]benzoic acid

-
4-[[(8-hydroxyquinolin-7-yl)(4-methylphenyl)methyl]amino]benzoic acid
-
-
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoic acid

-
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoic acid
-
-
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzonitrile

52% residual activity at 0.01 mM
4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzonitrile
-
-
4-[[cyclohexyl(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid

-
4-[[cyclohexyl(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
-
-
5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1H-1,2,3-triazole-4-carboxamide

also known as carboxyamidotriazole or L651582
5-amino-1-[3,5-dichloro-4-(4-chlorobenzoyl)benzyl]-1H-1,2,3-triazole-4-carboxamide
-
also known as carboxyamidotriazole or L651582
7-[(4-nitrophenyl)(phenylamino)methyl]quinolin-8-ol

-
7-[(4-nitrophenyl)(phenylamino)methyl]quinolin-8-ol
-
-
7-[phenyl(phenylamino)methyl]quinolin-8-ol

-
7-[phenyl(phenylamino)methyl]quinolin-8-ol
-
-
7-[[(4-methylphenyl)amino](phenyl)methyl]quinolin-8-ol

-
7-[[(4-methylphenyl)amino](phenyl)methyl]quinolin-8-ol
-
-
barangcadoic acid A

-
-
barangcadoic acid A
-
-
-
ethyl 4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoate

52% residual activity at 0.01 mM
ethyl 4-[[(8-hydroxyquinolin-7-yl)(phenyl)methyl]amino]benzoate
-
-
Mersalyl acid

-
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide

-
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide
-
non-peptidyl non-prenylic inhibitor B
N-acetyl-S-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cysteinyl-L-valyl-L-isoleucyl-L-alanine

-
N-acetyl-S-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cysteinyl-L-valyl-L-isoleucyl-L-alanine
-
-
N-ethylmaleimide

-
-
N-tert-Boc-S-farnesyl-L-cysteine chloromethyl ketone

-
-
N-tert-Boc-S-farnesyl-L-cysteine chloromethyl ketone
-
-
-
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide

-
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide
-
non-peptidyl non-prenylic inhibitor C
Nalpha-tosyl-L-lysine chloromethyl ketone

-
Nalpha-tosyl-L-lysine chloromethyl ketone
-
-
Nalpha-tosyl-L-phenylalanine chloromethyl ketone

-
Nalpha-tosyl-L-phenylalanine chloromethyl ketone
-
-
rhopaloic acid A

-
-
rhopaloic acid B

-
-
rhopaloic acid C

-
-
rhopaloic acid D

-
-
rhopaloic acid E

-
-
rhopaloic acid F

-
-
rhopaloic acid G

-
-
UM96001

-
-
additional information

-
not inhibited by EDTA
-
additional information
not inhibited by NSC66811
-
additional information
EDTA, EGTA, tetrakis-(2-pyridylmethyl)ethylenediamine, bestatin, antipain, chymostatin, pepstatin A, leupeptin, E64, and phenylmethylsulfonyl fluoride have no effect on the enzyme activity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.014
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide
0.0094
2-[(4-bromo-2,6-difluorophenyl)(phenylamino)methyl]naphthalen-1-ol
Homo sapiens
pH and temperature not specified in the publication
0.005
2-[(4-tert-butylanilino)(phenyl)methyl]naphthalen-1-ol
Homo sapiens
pH and temperature not specified in the publication
0.0049
2-[phenyl(phenylamino)methyl]naphthalen-1-ol
Homo sapiens
pH and temperature not specified in the publication
0.0053
3-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0054
4-bromo-2-[phenyl(phenylamino)methyl]naphthalen-1-ol
Homo sapiens
pH and temperature not specified in the publication
0.0042
4-[[(1-hydroxynaphthalen-2-yl)(phenyl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0038
4-[[(4-bromo-2,6-difluorophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0039
4-[[(4-bromophenyl)(1-hydroxynaphthalen-2-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0067
4-[[(4-bromophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.016
4-[[(4-cyanophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0082
4-[[(4-fluorophenyl)(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0071
4-[[(8-hydroxyquinolin-7-yl)(4-methylphenyl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.0098
4-[[cyclohexyl(8-hydroxyquinolin-7-yl)methyl]amino]benzoic acid
Homo sapiens
pH and temperature not specified in the publication
0.011
7-[(4-nitrophenyl)(phenylamino)methyl]quinolin-8-ol
Homo sapiens
pH and temperature not specified in the publication
0.089
7-[phenyl(phenylamino)methyl]quinolin-8-ol
Homo sapiens
pH and temperature not specified in the publication
0.0088
7-[[(4-methylphenyl)amino](phenyl)methyl]quinolin-8-ol
Homo sapiens
pH and temperature not specified in the publication
0.0081
dansyl-G(farnesyl)CIIS
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0057
dansyl-G(geranylgeranyl)CIIS
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.0031
dansyl-GLP(farnesyl)CVVM
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0095
dansyl-GLP(geranylgeranyl)CVVM
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.0015
dansyl-KTK(farnesyl)CVIM
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0023
dansyl-KTK(geranylgeranyl)CVIM
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.0053
dansyl-SAK(farnesyl)CVLS
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0062
dansyl-WDPA(farnesyl)CVIA
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0018
dansyl-WDPA(geranylgeranyl)CVIA
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.007
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide
0.002
N-acetyl-S-farnesyl-L-cysteine chloromethyl ketone
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.0152
N-acetyl-S-farnesyl-L-cysteine diazomethyl ketone
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.007
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide
0.001
poly(methylhydrosiloxane)
Saccharomyces cerevisiae
at pH 7.4 and 37°C
-
0.035
tosyl-L-phenylalanine chloromethyl ketone
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.0116
Zn2+
Saccharomyces cerevisiae
at pH 7.4 and 37°C
0.014
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide

Homo sapiens
pH and temperature not specified in the publication
0.014
(9Z,12Z)-N-(3-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-3-oxopropyl)octadeca-9,12-dienamide
Saccharomyces cerevisiae
-
pH and temperature not specified in the publication
0.007
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide

Homo sapiens
pH and temperature not specified in the publication
0.007
N-(2-[3-[(2,3-dimethylphenyl)sulfamoyl]anilino]-2-oxoethyl)heptadecanamide
Saccharomyces cerevisiae
-
pH and temperature not specified in the publication
0.007
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide

Homo sapiens
pH and temperature not specified in the publication
0.007
N3-[(2E)-3-([1,1'-biphenyl]-4-yl)prop-2-enoyl]-N-[3-[(2,3-dimethylphenyl)sulfamoyl]phenyl]-beta-alaninamide
Saccharomyces cerevisiae
-
pH and temperature not specified in the publication
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Hollander, I.; Frommer, E.; Mallon, R.
Human Ras-Converting Enzyme (hRCE1) Endoproteolytic Activity on K-Ras-Derived Peptides
Anal. Biochem.
286
129-137
2000
Homo sapiens (Q9Y256)
brenda
Dolence, J.M.; Steward, L.E.; Dolence, E.K.; Wong, D.H.; Poulter, C.D.
Studies with Recombinant Saccharomyces cerevisiae CaaX Prenyl Protease Rce1p
Biochemistry
39
4096-4104
2000
Saccharomyces cerevisiae (Q03530)
brenda
Otto, J.C.; Kim, E.; Young, S.G.; Casey, P.J.
Cloning and characterization of a mammalian prenyl protein-specific protease
J. Biol. Chem.
274
8379-8382
1999
Homo sapiens (Q9Y256)
brenda
Trueblood, C.E.; Boyartchuk, V.L.; Picologlou, E.A.; Rozema, D.; Poulter, C.D.; Rine, J.
The CaaX proteases, Afc1p and Rce1p, have overlapping but distinct substrate specificities
Mol. Cell. Biol.
20
4381-4392
2000
Saccharomyces cerevisiae (Q03530)
brenda
Pei, J.; Grishin, N.V.
Type II CAAX prenyl endopeptidases belong to a novel superfamily of putative membrane-bound metalloproteases
Trends Biochem. Sci.
26
275-277
2001
Saccharomyces cerevisiae (Q03530)
brenda
Plummer, L.J.; Hildebrandt, E.R.; Porter, S.B.; Rogers, V.A.; McCracken, J.; Schmidt, W.K.
Mutational analysis of the ras converting enzyme reveals a requirement for glutamate and histidine residues
J. Biol. Chem.
281
4596-4605
2006
Saccharomyces cerevisiae (Q03530)
brenda
Kyro, K.; Manandhar, S.P.; Mullen, D.; Schmidt, W.K.; Distefano, M.D.
Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate
Bioorg. Med. Chem.
18
5675-5684
2010
Saccharomyces cerevisiae (Q03530)
brenda
Pei, J.; Mitchell, D.; Dixon, J.; Grishin, N.
Expansion of type II CAAX proteases reveals evolutionary origin of gamma-secretase subunit APH-1
J. Mol. Biol.
410
18-26
2011
Saccharomyces cerevisiae (Q03530)
brenda
Christiansen, J.R.; Kolandaivelu, S.; Bergo, M.O.; Ramamurthy, V.
RAS-converting enzyme 1-mediated endoproteolysis is required for trafficking of rod phosphodiesterase 6 to photoreceptor outer segments
Proc. Natl. Acad. Sci. USA
108
8862-8866
2011
Mus musculus (P57791)
brenda
Cadinanos, J.; Schmidt, W.K.; Fueyo, A.; Varela, I.; Lopez-Otin, C.; Freije, J.M.
Identification, functional expression and enzymic analysis of two distinct CaaX proteases from Caenorhabditis elegans
Biochem. J.
370
1047-1054
2003
Caenorhabditis elegans (G5EEP3)
brenda
Jang, G.F.; Gelb, M.H.
Substrate specificity of mammalian prenyl protein-specific endoprotease activity
Biochemistry
37
4473-4481
1998
Rattus norvegicus (B0BMW8)
brenda
Hildebrandt, E.R.; Davis, D.M.; Deaton, J.; Krishnankutty, R.K.; Lilla, E.; Schmidt, W.K.
Topology of the yeast Ras converting enzyme as inferred from cysteine accessibility studies
Biochemistry
52
6601-6614
2013
Saccharomyces cerevisiae (Q03530)
brenda
Kyro, K.; Manandhar, S.P.; Mullen, D.; Schmidt, W.K.; Distefano, M.D.
Photoaffinity labeling of Ras converting enzyme using peptide substrates that incorporate benzoylphenylalanine (Bpa) residues improved labeling and structural implications
Bioorg. Med. Chem.
19
7559-7569
2011
Saccharomyces cerevisiae (Q03530)
brenda
Hampton, S.E.; Dore, T.M.; Schmidt, W.K.
Rce1 mechanism and inhibition
Crit. Rev. Biochem. Mol. Biol.
53
157-174
2018
Homo sapiens (Q9Y256), Saccharomyces cerevisiae
brenda
Cadinanos, J.; Varela, I.; Mandel, D.A.; Schmidt, W.K.; Diaz-Perales, A.; Lopez-Otin, C.; Freije, J.M.
AtFACE-2, a functional prenylated protein protease from Arabidopsis thaliana related to mammalian Ras-converting enzymes
J. Biol. Chem.
278
42091-42097
2003
Arabidopsis thaliana
brenda
Manolaridis, I.; Kulkarni, K.; Dodd, R.B.; Ogasawara, S.; Zhang, Z.; Bineva, G.; Reilly, N.O.; Hanrahan, S.J.; Thompson, A.J.; Cronin, N.; Iwata, S.; Barford, D.
Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1
Nature
504
301-305
2013
Methanococcus maripaludis (Q6LZY8)
brenda